Your browser doesn't support javascript.
loading
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer.
Sivakumar, Shivan; Abu-Shah, Enas; Ahern, David J; Arbe-Barnes, Edward H; Jainarayanan, Ashwin K; Mangal, Nagina; Reddy, Srikanth; Rendek, Aniko; Easton, Alistair; Kurz, Elke; Silva, Michael; Soonawalla, Zahir; Heij, Lara R; Bashford-Rogers, Rachael; Middleton, Mark R; Dustin, Michael L.
Affiliation
  • Sivakumar S; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
  • Abu-Shah E; Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.
  • Ahern DJ; Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Arbe-Barnes EH; Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.
  • Jainarayanan AK; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
  • Mangal N; Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.
  • Reddy S; University of Oxford Medical School, Oxford OX1 2JD, UK.
  • Rendek A; Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.
  • Easton A; Interdisciplinary Bioscience Doctoral Training Program and Exeter College, University of Oxford, Oxford OX3 7DQ, UK.
  • Kurz E; Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK.
  • Silva M; Department of Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Soonawalla Z; Department of Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Heij LR; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
  • Bashford-Rogers R; Kennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.
  • Middleton MR; Department of Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Dustin ML; Department of Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
Cancers (Basel) ; 13(8)2021 Apr 08.
Article in En | MEDLINE | ID: mdl-33917832
ABSTRACT
Pancreatic cancer has one of the worst prognoses of any human malignancy and leukocyte infiltration is a major prognostic marker of the disease. As current immunotherapies confer negligible survival benefits, there is a need to better characterise leukocytes in pancreatic cancer to identify better therapeutic strategies. In this study, we analysed 32 human pancreatic cancer patients from two independent cohorts. A multi-parameter mass-cytometry analysis was performed on 32,000 T-cells from eight patients. Single-cell RNA sequencing dataset analysis was performed on a cohort of 24 patients. Multiplex immunohistochemistry imaging and spatial analysis were performed to map immune infiltration into the tumour microenvironment. Regulatory T-cell populations demonstrated highly immunosuppressive states with high TIGIT, ICOS and CD39 expression. CD8+ T-cells were found to be either in senescence or an exhausted state. The exhausted CD8 T-cells had low PD-1 expression but high TIGIT and CD39 expression. These findings were corroborated in an independent pancreatic cancer single-cell RNA dataset. These data suggest that T-cells are major players in the suppressive microenvironment of pancreatic cancer. Our work identifies multiple novel therapeutic targets that should form the basis for rational design of a new generation of clinical trials in pancreatic ductal adenocarcinoma.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Reino Unido